Straits Times Index
2,544.15-1.36(-0.05%)S&P 500
3,342.03-18.44(-0.55%)Dow
27,756.44-35.00(-0.13%)
Pfizer Inc. (PFE)
| Previous close | 38.39 |
| Open | 38.56 |
| Bid | 37.88 x 2900 |
| Ask | 37.89 x 900 |
| Day's range | 37.77 - 38.58 |
| 52-week range | 27.88 - 40.97 |
| Volume | 15,401,524 |
| Avg. volume | 31,352,592 |
| Market cap | 210.189B |
| Beta (5Y monthly) | 0.73 |
| PE ratio (TTM) | 14.97 |
| EPS (TTM) | 2.53 |
| Earnings date | 27 Oct 2020 - 02 Nov 2020 |
| Forward dividend & yield | 1.52 (3.96%) |
| Ex-dividend date | 30 Jul 2020 |
| 1y target est | 41.85 |
- Editor's pickYahoo Finance
Coronavirus update: Russia approves world's first vaccine amid skepticism, Trump weighs travel ban on Americans
Latest news and updates and the global coronavirus pandemic.
- Motley Fool
Should Pfizer Be Your Next Coronavirus Buy?
The coronavirus pandemic has the world's drugmakers working together to deliver medical solutions and some companies are poised to contribute more than others. With a coronavirus vaccine candidate in late-stage clinical trials and a contract to help manufacture the only COVID-19 antiviral treatment available at the moment, Pfizer (NYSE: PFE) is contributing more than the vast majority of its big pharma peers. Do Pfizer's contributions to the fight against the COVID-19 pandemic make it a good stock to buy right now?
- Motley Fool
ICU Medical Inc (ICUI) Q2 2020 Earnings Call Transcript
Ladies and gentlemen, thank you for standing by and welcome to Q2 2020 ICU Medical, Inc. Earnings Conference Call. Thank you for joining us today to discuss the ICU Medical financial results for the second quarter of 2020. On the call today representing ICU Medical is Vivek Jain, Chief Executive Officer and Chairman and Brian Bonnell, Chief Financial Officer.
